日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The risk of reactivity against healthy tissues: Novel CARs demand testing for overlooked binding properties

对健康组织产生反应的风险:新型CAR需要进行被忽视的结合特性测试

Holzinger, Astrid; Weber, Florian; Abken, Hinrich

Integrating binding affinity and tonic signaling enables a rational CAR design for augmented T cell function.

结合亲和力和持续信号传导可以实现合理的 CAR 设计,从而增强 T 细胞功能

Barden Markus, Elsenbroich Patrick Ronan, Haas Vivian, Ertelt Moritz, Pervan Philip, Velas Lukas, Gergely Bence, Szöőr Árpád, Harrer Dennis Christoph, Bezler Valerie, Holzinger Astrid, Friis Rasmus Ulslev Wegener, Vereb Gyorgy, Schütz Gerhard J, Schoeder Clara T, Hombach Andreas A, Abken Hinrich

Automated manufacturing and characterization of clinical grade autologous CD20 CAR T cells for the treatment of patients with stage III/IV melanoma

用于治疗 III/IV 期黑色素瘤患者的临床级自体 CD20 CAR T 细胞的自动化生产和表征

Aleksandrova, Krasimira; Leise, Jana; Priesner, Christoph; Aktas, Murat; Apel, Michael; Assenmacher, Mario; Bürger, Iris; Richter, Anne; Altefrohne, Pia; Schubert, Christine; Holzinger, Astrid; Barden, Markus; Bezler, Valerie; von Bergwelt-Baildon, Michael; Borchmann, Peter; Goudeva, Lilia; Glienke, Wolfgang; Arseniev, Lubomir; Esser, Ruth; Abken, Hinrich; Koehl, Ulrike

CAR Triggered Release of Type-1 Interferon Limits CAR T-Cell Activities by an Artificial Negative Autocrine Loop

CAR触发的I型干扰素释放通过人工负向自分泌环路限制CAR T细胞活性

Harrer, Dennis Christoph; Schenkel, Charlotte; Bezler, Valerie; Kaljanac, Marcell; Hartley, Jordan; Barden, Markus; Pan, Hong; Holzinger, Astrid; Herr, Wolfgang; Abken, Hinrich

CAR T Cells: A Snapshot on the Growing Options to Design a CAR

CAR-T细胞:CAR设计方案的不断涌现概览

Holzinger, Astrid; Abken, Hinrich